Disclosure under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Prevest Denpro Limited has filed a quarterly statement confirming that the funds raised through its Initial Public Offering in September 2021 have been used entirely as per the original objects stated in the Prospectus, with no deviation or variation. The company raised ₹26.61 crore via a fresh issue, intended for purchasing machinery and equipment for new and existing manufacturing lines, an R&D unit, general corporate purposes, and issue expenses. The disclosure covers the quarter and year ended December 31, 2025. No monitoring agency was applicable, and the Audit Committee and Auditors had no comments.